Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Omicron jab gets provisional green light

A Pfizer booster that specifically tackles two Omicron COVID-19 variants has been given provisional approval by the Therapeutic Goods Administration.

AAP

With authorities in Queensland scaling back COVID protocols, here’s a look back at where we were 12, 24 and 36 months ago

Queensland's fourth year of living with COVID-19 begins today – marking the anniversary of the first time the state's then Chief Health Officer Jeannette Young warned the public of a novel coronavirus emerging out of China.

ABC News

ATAGI is considering a fifth COVID-19 vaccine dose, but how many boosters should I already have and who is eligible?

The federal government is waiting on advice about whether Australians should have a fifth COVID-19 vaccine. So, how many people have had the current boosters and who is eligible for what?

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

These Are the 3 Best Stocks on Wall Street to Buy Now

Although inflation moderated for the sixth consecutive month in December, a recession is still likely as the Fed is expected to keep raising rates this year. Amid an uncertain economic backdrop, fundamentally strong and popular stocks on Wall Street, Microsoft (MSFT), Pfizer (PFE), and AT&T (T), could make ideal additions…

StockNews.com

Obesity treatments catch drugmakers’ eyes as sales seen soaring

Three years ago, drugmakers and laboratories around the world responded to the pandemic with Covid-19 vaccines. Now that the urgency has faded, they’re collectively turning attention to an older pandemic: obesity.

Tribune News Service

Chinese Authorities Seize Fake Paxlovid Anti-Covid Pills

Amid pandemic surge and short supply, counterfeit pills flood booming black market for Pfizer treatment and generics from India

Caixin Global

CDC investigating possible link between updated Pfizer Covid vaccine and increased stroke risk among over-65s

"We believe it is important to share this information with the public"

Irish Mirror

Read news from The Economist, FT, and more,
with one subscription

CDC to investigate possible link between updated Pfizer Covid vaccine and increased stroke risk among over-65s

'It is very unlikely that the signal would represent a true clinical risk, we believe it is important to share this information with the public'

Wales Online

NHS heart doctor who championed Covid vaccines now wants jabs suspended after death of his father

Dr Aseem Malhotra believes booster was a factor in his father's death at 73 but other specialists insist vaccine saves lives on a huge scale

Wales Online

Weekly Must-Read: China Wraps Up Two-Year Tech Crackdown

Central bank and banking regulator’s Guo Shuqing sends first signal that sector led by Alibaba, Tencent, Didi and Meituan may finally be off the hook

Caixin Global

3 Stocks Investors Should Pour Their Money Into in 2023

While inflation has been showing signs of cooling recently, it is still far beyond the Fed’s target rate. Consequently, the Fed is expected to keep raising the interest rates for some time, fueling the chances of a global recession. Therefore, it could be wise to invest in well-performing stocks Pfizer…

StockNews.com

China suspends issuing visas in Japan, South Korea to retaliate for COVID-19 tests for travellers putting Australia at risk of similar treatment

Beijing halts visa processing in South Korea and Japan in protest at what it says are "discriminatory" entry test rules imposed on travellers from China by a range of countries, including Australia.

ABC News

The 'Kraken' COVID variant taking hold in the U.S. Here's how many vaccine shots there are—and what experts recommend to protect yourself

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Fortune

First real-world data show omicron booster kept seniors out of hospitals

In the first real-world test of vaccine boosters specially designed to protect against the omicron variant, Israeli researchers have found that people 65 and over who got an updated jab were 81% less likely to be hospitalized with COVID-19 than those who did not.

Los Angeles Times

Get all your
news in one place.

100's of premium titles.
One news app.

Caixin Global

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

The Independent UK

Pfizer's Paxlovid not included in China's national insurance

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Caixin Global

Weekly Must-Read: China’s Road to Economic Recovery Faces Post-Covid Speed Bumps

Policymakers are now squarely focused on reviving the economy. But some analysts warned against ‘excessive optimism’ about when pre-pandemic growth rates will return

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Investing Champion Leif Soreide Notes Biotech Stocks May Be Countercyclical

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

The National (Scotland)

Tory MP condemns colleague's 'nonsense' claims about Covid vaccines

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

StockNews.com

1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

WEKU

China's COVID vaccines: Do the jabs do the job?

As case counts surge in China, rumors circulate about the effectiveness and safety of the made-in-China vaccines in use there. Here's what we know about CoronaVac and Sinopharm.

Caixin Global

Health care centers from Guangzhou to Shijiazhuang and Beijing are slammed amid surging infections and severe shortages of medical workers

StockNews.com

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

StockNews.com

2 COVID-19 Stocks That Are Still Strong Buys

Given that COVID-19 is here to stay for the foreseeable future, investors could still benefit from their investments in companies that saw record-breaking sales during the pandemic’s height because of the effectiveness of their products in fighting the virus. With the potential resurgence of COVID-19 in several countries, Pfizer (PFE)…

1 … 31 32 33 34

People

Mangeet Kaur BounsMangeet

595 stories

Annastacia Palaszczuk

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.